Source: Pharmac
2 June 2020
What we’re doing
We are pleased to announce the approval of a listing agreement with Device Technologies New Zealand Limited (“Device Technologies”) for the supply of obstetrics and gynaecology products to DHBs.
In summary this will result in:
- Device Technologies products being listed in Part III of Section H of the Pharmaceutical Schedule from 1 July 2020 under a national agreement that all DHBs may purchase under (“Agreement”); and
- DHBs being able to continue to purchase other suppliers’ brands of obstetrics and gynaecology products.
Any changes to the original proposal?
This decision was subject to a consultation letter dated 20 April 2020.
No changes were made to the agreement following consultation feedback.
Who we think will be most interested
- Suppliers and wholesalers
- DHB clinical staff in a range of clinical settings including:
- Obstetricians and Gynaecologists
- Clinical/Biomedical Engineers
- Sterile services staff
- Outpatient clinic staff
- Surgeons
- Theatre and perioperative staff
- Surgical, speciality units, gynaecology and general ward staff
- Delivery suite staff
- Midwives
- Point of Care coordinators
- Medical Scientists
- Laboratory Managers
- DHB procurement and supply chain personnel
Details about this decision
In 2018, PHARMAC issued a Request for Proposal (“RFP”) for obstetric and gynaecology products.
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
After completing the RFP evaluation processes, and consulting on the provisional Agreement reached with Device Technologies, PHARMAC has decided to list Device Technologies medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 July 2020.
DHBs can continue to choose which obstetrics and gynaecology products they purchase, including those from other suppliers. DHBs that purchase obstetrics and gynaecology products from Device Technologies must do so under the terms and conditions, including pricing, in the Agreement, from 1 July 2020.
The Agreement includes terms and conditions for training and education to be provided by Device Technologies on the appropriate use of its products, which is to be provided at times as agreed with individual DHBs.
Our response to what you told us
All consultation responses received by 15 May 2020 were considered in their entirety in making the decision to list Device Technologies’ obstetrics and gynecology products.
A summary of the main themes raised in feedback and our responses to the feedback are set out below:
|
Theme |
Comment |
|---|---|
|
Advised no technical or resource impacts are expected as a result of the proposal. |
Noted. |
|
Surgical trays individually should weigh less than 10 kg to meet Health & Safety guidelines and noted that New Zealand Nurses Organisation (NZNO) Perioperative Nurses college guidelines is for 7kg. |
Noted. The preparation of surgical trays will remain an operational decision by individual DHBs and is therefore unaffected by the devices in this consultation. |
If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.
Last updated: 2 June 2020
